NO904291L - Fremgangsmaate for fremstilling av radiomerkede antikoagulerende peptider. - Google Patents

Fremgangsmaate for fremstilling av radiomerkede antikoagulerende peptider.

Info

Publication number
NO904291L
NO904291L NO90904291A NO904291A NO904291L NO 904291 L NO904291 L NO 904291L NO 90904291 A NO90904291 A NO 90904291A NO 904291 A NO904291 A NO 904291A NO 904291 L NO904291 L NO 904291L
Authority
NO
Norway
Prior art keywords
anticoagulating
peptides
marked
radio
procedure
Prior art date
Application number
NO90904291A
Other languages
English (en)
Norwegian (no)
Other versions
NO904291D0 (no
Inventor
John Leonard Krstenansky
Simon Jen Tan Mao
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO904291D0 publication Critical patent/NO904291D0/no
Publication of NO904291L publication Critical patent/NO904291L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/815—Protease inhibitors from leeches, e.g. hirudin, eglin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO90904291A 1989-10-03 1990-10-02 Fremgangsmaate for fremstilling av radiomerkede antikoagulerende peptider. NO904291L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41633589A 1989-10-03 1989-10-03

Publications (2)

Publication Number Publication Date
NO904291D0 NO904291D0 (no) 1990-10-02
NO904291L true NO904291L (no) 1991-04-04

Family

ID=23649537

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90904291A NO904291L (no) 1989-10-03 1990-10-02 Fremgangsmaate for fremstilling av radiomerkede antikoagulerende peptider.

Country Status (18)

Country Link
US (1) US5279812A (fr)
EP (1) EP0421366B1 (fr)
JP (1) JP2899390B2 (fr)
KR (1) KR0168644B1 (fr)
CN (1) CN1050721A (fr)
AT (1) ATE125269T1 (fr)
AU (1) AU631681B2 (fr)
CA (1) CA2026377A1 (fr)
DE (1) DE69021000T2 (fr)
ES (1) ES2076999T3 (fr)
FI (1) FI904851A0 (fr)
HU (1) HU207525B (fr)
IE (1) IE903531A1 (fr)
IL (1) IL95864A0 (fr)
NO (1) NO904291L (fr)
NZ (1) NZ235499A (fr)
PT (1) PT95485A (fr)
ZA (1) ZA907743B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395609A (en) * 1989-06-19 1995-03-07 Antisoma Limited Synthetic peptides for use in tumor detection
GB8914020D0 (en) * 1989-06-19 1989-08-09 Antisoma Ltd Synthetic peptides for use in thrombus detection
ZA915658B (en) * 1990-07-24 1992-05-27 Merrell Dow Pharma Analogs of hirudin having antiplatelet activity
CA2086243C (fr) * 1990-07-24 2001-10-02 John L. Krstenansky Peptides anticoagulants
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
WO1993004082A1 (fr) * 1991-08-20 1993-03-04 Baxter International Inc. Analogues de l'hirudine
US5371184A (en) * 1992-02-05 1994-12-06 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
ATE203417T1 (de) * 1992-02-05 2001-08-15 Mallinckrodt Inc Radioaktiv markierte somatostatin
US5750088A (en) 1993-03-30 1998-05-12 The Dupont Merck Pharmaceutical Company Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
DE69432983T2 (de) * 1993-06-11 2004-04-29 Merrell Pharmaceuticals Inc., Cincinnati Trifunktionelle antithrombin-und antiplättchenpeptide
US5457177A (en) * 1993-06-16 1995-10-10 Merck & Co., Inc. Thrombin receptor radioligands
WO1995032173A1 (fr) * 1994-05-24 1995-11-30 Eisai Co., Ltd. Compose porteur de deux groupes 2,6-diiodophenol-4-yl et medicament de diagnostic de l'allergie a l'iode
US5808146A (en) * 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
US6808698B1 (en) 1999-03-26 2004-10-26 Bristol-Myers Squibb Pharma Company Method for localization of blood clots
US6254852B1 (en) 1999-07-16 2001-07-03 Dupont Pharmaceuticals Company Porous inorganic targeted ultrasound contrast agents
US6685914B1 (en) * 1999-09-13 2004-02-03 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
EP1499584B1 (fr) * 2002-04-30 2010-08-18 Emory University Composes pour l'imagerie de tumeurs
US7319149B2 (en) * 2003-06-13 2008-01-15 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
US7317104B2 (en) 2003-06-13 2008-01-08 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
CN100402092C (zh) * 2005-06-07 2008-07-16 西安交通大学 血栓诊断和/或治疗用含气干粉活性剂及其制备工艺
US20060292073A1 (en) * 2005-06-23 2006-12-28 Emory University Stereoselective Synthesis of Amino Acid Analogs for Tumor Imaging
EP1893244A4 (fr) 2005-06-23 2009-06-24 Univ Emory Agents pour l'imagerie
US8246752B2 (en) 2008-01-25 2012-08-21 Clear Catheter Systems, Inc. Methods and devices to clear obstructions from medical tubes
CN110437307B (zh) * 2019-07-26 2020-11-13 暨南大学 一类具抗血栓和脑神经细胞保护作用的水蛭多肽及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5850213B2 (ja) * 1977-06-20 1983-11-09 株式会社第一ラジオアイソト−プ研究所 カルチトニンの定量法
DE3040824A1 (de) * 1980-10-30 1982-08-19 Dr. Karl Thomae Gmbh, 7950 Biberach Neues dekapeptid, verfahren zu seiner herstellung und verwendung
US4455290A (en) * 1981-04-02 1984-06-19 Research Corporation Inhibition of fibrin polymerization by a peptide isolated from fibrin Fragment D1
US4585740A (en) * 1983-05-03 1986-04-29 The Whittier Institute For Diabetes And Endocrinology Prolactin immunoassay using synthetic peptide
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3689525D1 (de) * 1985-07-17 1994-02-24 Hoechst Ag Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel.
CA1341032C (fr) * 1987-01-23 2000-06-20 John L. Krstenansky Peptides anti-coagulants
ZA883444B (fr) * 1987-05-21 1988-11-16
CA1340646C (fr) * 1987-05-21 1999-07-13 John L. Krstenansky Peptides cycliques anticoagulants
AU3098289A (en) * 1988-03-04 1989-09-07 Biogen, Inc. Hirudin peptides
ES2052062T3 (es) * 1988-06-11 1994-07-01 Ciba Geigy Ag Nuevos polipeptidos con actividad anticoagulante.
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides

Also Published As

Publication number Publication date
ES2076999T3 (es) 1995-11-16
US5279812A (en) 1994-01-18
NO904291D0 (no) 1990-10-02
JP2899390B2 (ja) 1999-06-02
HUT55801A (en) 1991-06-28
IL95864A0 (en) 1991-07-18
IE903531A1 (en) 1991-04-10
KR0168644B1 (ko) 1999-01-15
EP0421366A1 (fr) 1991-04-10
AU631681B2 (en) 1992-12-03
AU6368990A (en) 1991-04-11
CA2026377A1 (fr) 1991-04-04
DE69021000D1 (de) 1995-08-24
HU906271D0 (en) 1991-03-28
ZA907743B (en) 1991-07-31
CN1050721A (zh) 1991-04-17
JPH03120296A (ja) 1991-05-22
EP0421366B1 (fr) 1995-07-19
FI904851A0 (fi) 1990-10-02
KR910007959A (ko) 1991-05-30
HU207525B (en) 1993-04-28
PT95485A (pt) 1991-06-25
DE69021000T2 (de) 1996-04-04
NZ235499A (en) 1993-04-28
ATE125269T1 (de) 1995-08-15

Similar Documents

Publication Publication Date Title
NO904291D0 (no) Fremgangsmaate for fremstilling av radiomerkede antikoagulerende peptider.
NO880268L (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
NO904292D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
NO882238L (no) Fremgangsmaate for fremstilling av cykliske antikoagulerende peptider.
DE3880194D1 (de) Zyklisches antikoagulierendes peptid.
NO894880D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
NO891894L (no) Fremgangsmaate for fremstilling av antikoagulerende peptidalkoholer.
HU9300191D0 (en) Anti-coagulant peptides